MoonLake Immunotherapeutics (MLTX) Exchange Rate Effect (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) recorded quarterly Exchange Rate Effect of -$483000.0 in Q1 2026, down 630.77% quarter-over-quarter from $91000.0 in Q4 2025, and down 448.86% on a YoY basis from $138449.5 in Q1 2025.
MoonLake Immunotherapeutics (MLTX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$483000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 448.86% year-over-year to -$483000.0; the TTM figure through Mar 2026 stood at $714000.0 (up 12000.0% YoY), while the FY2025 annual figure was $1.1 million, up 766.41% from the prior year.
- Exchange Rate Effect was -$483000.0 for Q1 2026 at MoonLake Immunotherapeutics, down from $91000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.4 million in Q2 2025 to a low of -$483000.0 in Q1 2026.
- Historically, Exchange Rate Effect has averaged $40384.7 across 5 years, with a median of -$6504.0 in 2022.
- Biggest YoY gain for Exchange Rate Effect was 8698.13% in 2024; the steepest drop was 6592.21% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at -$8286.0 in 2022, then surged by 872.95% to $64047.0 in 2023, then soared by 562.01% to $424000.0 in 2024, then slumped by 78.54% to $91000.0 in 2025, then tumbled by 630.77% to -$483000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$483000.0 (Q1 2026), $91000.0 (Q4 2025), and -$285000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - | -483,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -483,000.00 |
| Mar 31, 2026 | -483,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2025 | -285,000.00 |
| Sep 30, 2025 | -285,000.00 |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | -88,000.00 |
| Mar 31, 2025 | -88,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Sep 30, 2024 | -325,000.00 |
| Sep 30, 2024 | -325,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Mar 31, 2024 | 46,000.00 |
| Dec 31, 2023 | 64,047.00 |
| Dec 31, 2023 | 64,047.00 |